Articles dans des revues avec comité de lecture (224)
  1. 19. Dold, M., Bartova, L., Fugger, G., Kautzky, A., Mitschek, M. M. M., Fabbri, C., Montgomery, S., Zohar, J., Souery, D., Mendlewicz, J., Serretti, A., & Kasper, S. S. (2021). Melancholic features in major depression – a European multicenter study. Progress in neuro-psychopharmacology & biological psychiatry, 110, 110285. doi:10.1016/j.pnpbp.2021.110285
  2. 20. Taliaz, D., & Souery, D. (2021). A new characterization of mental health disorders using digital behavioral data: Evidence from major depressive disorder. Journal of Clinical Medicine, 10(14), 3109. doi:10.3390/jcm10143109
  3. 21. Bartova, L., Dold, M., Fugger, G., Kautzky, A., Mitschek, M. M. M., Weidenauer, A., Handschuh, P. A., Frey, R., Mandelli, L., Zohar, J., Mendlewicz, J., Souery, D., Montgomery, S., Fabbri, C., Serretti, A., & Kasper, S. S. (2021). The Role of Relationship Status in Major Depressive Disorder - Results of the European Group for the Study of Resistant Depression. Journal of affective disorders, 286, 149-157. doi:10.1016/j.jad.2021.02.070
  4. 22. Crisafulli, C., Calabrò, M., Mandelli, L., Wang, S. M., Lee, S. J., Han, C., Patkar, A., Masand, P., Pae, C. U., Souery, D., Mendlewicz, J., & Serretti, A. (2021). Possible modulatory role of ARC gene variants in mood disorders. Clinical Psychopharmacology and Neuroscience, 19(1), 46-52. doi:10.9758/CPN.2021.19.1.46
  5. 23. Fabbri, C., Kasper, S., Zohar, J., Souery, D., Montgomery, S., Albani, D., Forloni, G. L. G., Ferentinos, P., Rujescu, D., Mendlewicz, J., De Ronchi, D., Riva, M. A., Lewis, C. C., & Serretti, A. (2021). Drug repositioning for treatment-resistant depression: Hypotheses from a pharmacogenomic study. Progress in neuro-psychopharmacology & biological psychiatry, 104, 110050. doi:10.1016/j.pnpbp.2020.110050
  6. 24. Fabbri, C., Kasper, S., Zohar, J., Souery, D., Montgomery, S., Albani, D., Forloni, G. L. G., Ferentinos, P., Rujescu, D., Mendlewicz, J., Serretti, A., & Lewis, C. C. (2021). Cost-effectiveness of genetic and clinical predictors for choosing combined psychotherapy and pharmacotherapy in major depression. Journal of affective disorders, 279, 722-729. doi:10.1016/j.jad.2020.10.049
  7. 25. Calabrò, M., Fabbri, C., Kasper, S. S., Zohar, J., Souery, D., Montgomery, S., Albani, D., Forloni, G. L. G., Ferentinos, P., Rujescu, D., Mendlewicz, J., Colombo, R., De Ronchi, D., Serretti, A., & Crisafulli, C. (2021). Research domain criteria (Rdoc): A perspective to probe the biological background behind treatment efficacy in depression. Current medicinal chemistry, 28(22), 4296-4320. doi:10.2174/0929867328666210104104938
  8. 26. Bartova, L., Dold, M., Fugger, G., Kautzky, A., Mitschek, M. M. M., Weidenauer, A., Hienert, M. M., Frey, R., Mandelli, L., Zohar, J., Mendlewicz, J., Souery, D., Montgomery, S., Fabbri, C., Serretti, A., & Kasper, S. S. (2021). Sex-related effects in major depressive disorder: Results of the European Group for the Study of Resistant Depression. Depression and anxiety. doi:10.1002/da.23165
  9. 27. Fabbri, C., Kasper, S. S., Kautzky, A., Zohar, J., Souery, D., Montgomery, S., Albani, D., Forloni, G. L. G., Ferentinos, P., Rujescu, D., Mendlewicz, J., Uher, R., Lewis, C. C., & Serretti, A. (2020). A polygenic predictor of treatment-resistant depression using whole exome sequencing and genome-wide genotyping. Translational Psychiatry, 10(1), 50. doi:10.1038/s41398-020-0738-5
  10. 28. Fugger, G., Dold, M., Bartova, L., Mitschek, M. M. M., Souery, D., Mendlewicz, J., Serretti, A., Zohar, J., Montgomery, S., Fabbri, C., Frey, R., & Kasper, S. (2020). Clinical Correlates and Outcome of Major Depressive Disorder and Comorbid Migraine: A Report of the European Group for the Study of Resistant Depression. The international journal of neuropsychopharmacology, 23(9), 571-577. doi:10.1093/ijnp/pyaa035
  11. 29. Porcelli, S., Kasper, S., Zohar, J., Souery, D., Montgomery, S., Ferentinos, P., Rujescu, D., Mendlewicz, J., Merlo Pich, E., Pollentier, S., Penninx, B. B., & Serretti, A. (2020). Social dysfunction in mood disorders and schizophrenia: Clinical modulators in four independent samples. Progress in neuro-psychopharmacology & biological psychiatry, 99, 109835. doi:10.1016/j.pnpbp.2019.109835
  12. 30. Calabrò, M., Porcelli, S., Crisafulli, C., Albani, D., Kasper, S., Zohar, J., Souery, D., Montgomery, S., Mantovani, V., Mendlewicz, J., Bonassi, S., Vieta, E., Frustaci, A., Ducci, G., Landi, S., Boccia, S., Bellomo, A., Di Nicola, M., Janiri, L., Colombo, R., Benedetti, F., Mandelli, L., Fabbri, C., & Serretti, A. (2020). Genetic variants associated with psychotic symptoms across psychiatric disorders. Neuroscience letters, 720, 134754. doi:10.1016/j.neulet.2020.134754
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 Suivant >>